| Multi-omics correlates of insulin resistance and circadian parameters mapped directly from human serum | European journal of neuroscience | | | 2024 | 89 | 245 |
|
| Circadian organization of lipid landscape is perturbed in type 2 diabetic patients | Cell reports medicine | | | 2023 | 276 | 159 |
|
| The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomas | Endocrine | | | 2023 | 149 | 403 |
|
| Moderate to Severe Soft Tissue Diabetic Foot Infections: A Randomized, Controlled, Pilot Trial of Post-debridement Antibiotic Treatment for 10 versus 20 days | Annals of surgery | | | 2022 | 265 | 438 |
|
| Growth differentiation factor-15 prevents glucotoxicity and connexin-36 downregulation in pancreatic beta-cells | Molecular and cellular endocrinology | | | 2022 | 110 | 242 |
|
| Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patients | Acta Physiologica | | | 2021 | 403 | 3 |
|
| Sphingosine‐1‐phosphate as a key player of insulin secretion induced by high‐density lipoprotein treatment | Physiological reports | | | 2021 | 263 | 184 |
|
| Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: A prospective, randomized, non-inferiority pilot trial | Clinical Infectious Diseases | | | 2020 | 349 | 1,200 |
|
| Analogues du GLP-1 en 2019 : pour qui et comment ? | Revue médicale suisse | | | 2019 | 466 | 1 |
|
| Faut-il prescrire plus d'inhibiteurs SGLT-2 ? | Revue médicale suisse | | | 2019 | 311 | 173 |
|
| Cellular circadian period length inversely correlates with HbA1c levels in individuals with type 2 diabetes | Diabetologia | | | 2019 | 526 | 5 |
|
| High-fat diet impacts more changes in beta-cell compared to alpha-cell transcriptome | PloS one | | | 2019 | 7 | 57 |
|
| Association between polycystic ovary syndrome and venous thromboembolism: A systematic review and meta-analysis | Thrombosis Research | | | 2019 | 359 | 1 |
|
| Validation of molecular biomarkers for preoperative diagnostics of human papillary thyroid carcinoma in fine needle aspirates | Gland Surgery | | | 2019 | 506 | 5 |
|
| Observance thérapeutique et empilage médicamenteux | Revue médicale suisse | | | 2018 | 374 | 216 |
|
| Composite pheochromocytoma with neuroblastoma: a case report | 20th European Congress of Endocrinology | | | 2018 | 161 | 1 |
|
| Time zones of pancreatic islet metabolism | Diabetes, Obesity and Metabolism | | | 2018 | 476 | 0 |
|
| Identification of Differential Transcriptional Patterns in Primary and Secondary Hyperparathyroidism | Journal of Clinical Endocrinology and Metabolism | | | 2018 | 670 | 4 |
|
| Consequences of the Adoption of the IADPSG versus Carpenter and Coustan Criteria to Diagnose Gestational Diabetes: A Before-After Comparison | Experimental and Clinical Endocrinology and Diabetes | | | 2018 | 519 | 2 |
|
| Manifestations musculosquelettiques du diabète sucré : une complication fréquente | Revue médicale suisse | | | 2017 | 374 | 0 |
|
| Anti-CTLA-4 Monoclonal Antibodies Induced Hypophysitis: Case Report and Literature Review | Annals of Clinical Case Reports | | | 2017 | 457 | 180 |
|
| Traitement du diabète de type 2 : risques et bénéfices de la chirurgie métabolique | Revue médicale suisse | | | 2017 | 382 | 0 |
|
| Traitement du diabète: quand faire appel au diabétologue? | Revue médicale suisse | | | 2017 | 378 | 247 |
|
| Association des analogues du GLP-1 et des inhibiteurs du SGLT2 : de nouvelles perspectives ? | Revue médicale suisse | | | 2017 | 394 | 0 |
|
| The search for preoperative biomarkers for thyroid carcinoma: application of the thyroid circadian clock properties | Biomarkers in medicine | | | 2017 | 576 | 1 |
|
| Pancreatic α- and β-cellular clocks have distinct molecular properties and impact on islet hormone secretion and gene expression | Genes and Development | | | 2017 | 643 | 72 |
|
| Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples | Journal of Immunological Methods | | | 2017 | 404 | 1 |
|
| Prévention et guérison du diabète : est-ce possible ? | Revue médicale suisse | | | 2016 | 468 | 0 |
|
| Identification of CHEK1, SLC26A4, c-KIT, TPO and TG as new biomarkers for human follicular thyroid carcinoma | Oncotarget | | | 2016 | 680 | 302 |
|
| Functional and Molecular Adaptations of Enteroendocrine L-Cells in Male Obese Mice Are Associated With Preservation of Pancreatic α-Cell Function and Prevention of Hyperglycemia | Endocrinology | | | 2016 | 539 | 0 |
|
| Effects of liver transplantation on endocrine function: a systematic review | Liver international | | | 2016 | 559 | 4 |
|
| α-Cell Dysfunctions and Molecular Alterations in Male Insulinopenic Diabetic Mice Are Not Completely Corrected by Insulin | Endocrinology | | | 2016 | 620 | 1 |
|
| Comment faire pour prévenir le diabète de type 2 en Suisse? | Revue médicale suisse | | | 2016 | 426 | 2 |
|
| Dysthyroïdies liées à une surcharge iodée | Revue médicale suisse | | | 2016 | 402 | 0 |
|
| Insuline et antidiabétiques oraux : comment les associer dans la pratique ambulatoire ? | Revue médicale suisse | | | 2016 | 513 | 3 |
|
| Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway | Proceedings of the National Academy of Sciences of the United States of America | | | 2015 | 569 | 358 |
|
| Thyroid Circadian Timing: Roles in Physiology and Thyroid Malignancies | Journal of biological rhythms | | | 2015 | 697 | 0 |
|
| Free Fatty Acids Impair FGF21 Action in HepG2 Cells | Cellular physiology and biochemistry | | | 2015 | 565 | 864 |
|
| Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis | Canadian journal of diabetes | | | 2015 | 550 | 0 |
|
| Acute painful diabetic neuropathy: an uncommon, remittent type of acute distal small fibre neuropathy | Schweizerische medizinische Wochenschrift | | | 2015 | 602 | 2 |
|
| Erreurs innées du métabolisme: transition enfant-adulte | Revue médicale suisse | | | 2015 | 622 | 2 |
|
| Statins and Diabetes: The Plot Thickens | Journal of general internal medicine | | | 2015 | 462 | 0 |
|
| Le diabète en 2015 : en augmentation constante, mais avec une offre thérapeutique qui s'élargit | Revue médicale suisse | | | 2015 | 410 | 1 |
|
| Baisse de la déhydroépiandrostérone avec l'âge : pertinence clinique et intérêt thérapeutique | Revue médicale suisse | | | 2015 | 573 | 1 |
|
| Restoration of adrenal function after bilateral adrenal damage due to heparin-induced thrombocytopenia (HIT): a case report | Journal of medical case reports | | | 2015 | 683 | 345 |
|
| Endocrinologie :l'hyperparathyroïdie primaire asymptomatique en 2014 | Revue médicale suisse | | | 2015 | 511 | 1 |
|
| Identification of new biomarkers for human papillary thyroid carcinoma employing NanoString analysis | Oncotarget | | | 2015 | 786 | 452 |
|
| Diabétologie | Revue médicale suisse | | | 2015 | 497 | 0 |
|
| Analogues du GLP-1 versus inhibiteurs du SGLT-2 pour les diabétiques de type 2 obèses | Revue médicale suisse | | | 2015 | 508 | 1 |
|
| Syndrome des ovaires polykystiques : quoi de neuf ? | Revue médicale suisse | | | 2015 | 562 | 1 |
|
| Endocrinologie | Revue médicale suisse | | | 2014 | 558 | 0 |
|
| Maladies hépatiques chroniques et diabète | Revue médicale suisse | | | 2014 | 495 | 0 |
|
| Le concept de parcours de santé ou la difficile révolution de la prise en charge des maladies chroniques | Revue médicale suisse | | | 2014 | 480 | 0 |
|
| Foxa1 and Foxa2 regulate α-cell differentiation, glucagon biosynthesis, and secretion | Endocrinology | | | 2014 | 636 | 0 |
|
| La testostérone : un traitement pour la prévention des maladies cardiovasculaires ? | Revue médicale suisse | | | 2014 | 514 | 0 |
|
| Traitement combiné d'insuline et d'analogue du GLP-1 : qu'en attendre ? | Revue médicale suisse | | | 2014 | 580 | 0 |
|
| Quelle insuline pour quel patient en 2014 ? | Revue médicale suisse | | | 2014 | 464 | 0 |
|
| Glucagon: the renewal of an old hormone in the pathophysiology of diabetes | Journal of diabetes and its complications | | | 2013 | 598 | 0 |
|
| Autonomous and self-sustained circadian oscillators displayed in human islet cells | Diabetologia | | | 2013 | 761 | 229 |
|
| Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside | Diabetes & metabolism | | | 2013 | 653 | 0 |
|
| Circadian clock characteristics are altered in human thyroid malignant nodules | The Journal of clinical endocrinology and metabolism | | | 2013 | 768 | 2 |
|
| A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? | Rejuvenation research | | | 2013 | 778 | 1,116 |
|
| Implications of somatostatin analogues in the treatment of acromegaly | European endocrinology | | | 2013 | 373 | 246 |
|
| Hypoglycémie non diabétique : diagnostic et prise en charge | Revue médicale suisse | | | 2013 | 687 | 2 |
|
| Sport et diabète de type 1 | Revue médicale suisse | | | 2013 | 686 | 0 |
|
| Biofeedback can reduce foot pressure to a safe level and without causing new at-risk zones in patients with diabetes and peripheral neuropathy | Diabetes/metabolism research and reviews | | | 2013 | 623 | 1 |
|
| Maladies chroniques : le politique doit s'engager ! | Revue médicale suisse | | | 2013 | 436 | 1 |
|
| Diabète de la personne âgée : une prise en charge sur mesure | Revue médicale suisse | | | 2013 | 585 | 0 |
|
| Biological rhythms and preeclampsia | Frontiers in endocrinology | | | 2013 | 759 | 591 |
|
| Pax6 is a key component of regulated glucagon secretion | Endocrinology | | | 2012 | 1,063 | 0 |
|
| Sommeil et diabète | Revue médicale suisse | | | 2012 | 517 | 0 |
|
| Diabète et stéatose hépatique non alcoolique | Revue médicale suisse | | | 2012 | 638 | 0 |
|
| Néphropathie diabétique | Revue médicale suisse | | | 2012 | 666 | 1 |
|
| Hypothermia is a frequent sign of severe hypoglycaemia in patients with diabetes | Diabetes & metabolism | | | 2012 | 651 | 0 |
|
| Antidiabetic drugs and kidney disease--recommendations of the Swiss Society for Endocrinology and Diabetology | Schweizerische medizinische Wochenschrift | | | 2012 | 2,028 | 1,413 |
|
| La médecine personnalisée et la face cachée de la lune | Revue médicale suisse | | | 2012 | 502 | 1 |
|
| Pax6 is crucial for β-cell function, insulin biosynthesis, and glucose-induced insulin secretion | Molecular endocrinology | | | 2012 | 665 | 0 |
|
| Glucagon gene expression in the endocrine pancreas: the role of the transcription factor Pax6 in α-cell differentiation, glucagon biosynthesis and secretion | Diabetes, obesity & metabolism | | | 2011 | 656 | 0 |
|
| Glucagon responses of isolated α cells to glucose, insulin, somatostatin, and leptin | Endocrine practice | | | 2011 | 601 | 0 |
|
| Hémoglobine glyquée: nouvel outil de dépistage? | Revue médicale suisse | | | 2011 | 721 | 1 |
|
| Prise en charge du diabète gestationnel: nouvelles connaissances et perspectives futures | Revue médicale suisse | | | 2011 | 708 | 1 |
|
| Prise en charge du diabète et réseaux médicaux: est-ce la solution? | Revue médicale suisse | | | 2011 | 515 | 0 |
|
| Diagnostic et traitement de l'insuffisance pancréatique exocrine lors d'un diabète | Diabetes, Stoffwechsel und Herz | | | 2011 | 555 | 0 |
|
| Importance de la décharge dans le traitement des lésions du pied diabétique | Revue médicale suisse | | | 2011 | 565 | 1 |
|
| Multislice gated-computed tomography of cardiac paragangliomas | Journal of the American College of Cardiology | | | 2010 | 510 | 0 |
|
| Pax6 controls the expression of critical genes involved in pancreatic {alpha} cell differentiation and function | The Journal of biological chemistry | | | 2010 | 624 | 1 |
|
| Comment minimiser la prise de poids secondaire au traitement d'insuline? | Revue médicale suisse | | | 2010 | 644 | 0 |
|
| L'aspirine en prévention primaire chez les patients diabétiques | Revue médicale suisse | | | 2010 | 497 | 0 |
|
| Insuline et cancer: mythe ou realité? | Revue médicale suisse | | | 2010 | 600 | 0 |
|
| Diabète et cancer: une association pernicieuse | Revue médicale suisse | | | 2010 | 667 | 0 |
|
| Treating type 2 diabetes: how safe are current therapeutic agents? | International journal of clinical practice | | | 2009 | 554 | 0 |
|
| Pax6 regulates the proglucagon processing enzyme PC2 and its chaperone 7B2 | Molecular and cellular biology | | | 2009 | 645 | 0 |
|
| Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year mark | American journal of transplantation | | | 2009 | 984 | 6 |
|
| Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial | Diabetes, obesity & metabolism | | | 2008 | 890 | 8 |
|
| Mucocutaneous papillomatous papules in Cowden's syndrome | Clinical and experimental dermatology | | | 2008 | 561 | 0 |
|
| Motesanib diphosphate in progressive differentiated thyroid cancer | The New England journal of medicine | | | 2008 | 562 | 0 |
|
| Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol | American journal of transplantation | | | 2006 | 915 | 375 |
|
| Detection of insulin mRNA in the peripheral blood after human islet transplantion predicts deterioration of metabolic control | American journal of transplantation | | | 2006 | 897 | 325 |
|
| Severe congenital hyperinsulinism caused by a mutation in the Kir6.2 subunit of the adenosine triphosphate-sensitive potassium channel impairing trafficking and function | The Journal of clinical endocrinology and metabolism | | | 2005 | 726 | 463 |
|
| The zinc finger-containing transcription factor Gata-4 is expressed in the developing endocrine pancreas and activates glucagon gene expression | Molecular endocrinology | | | 2005 | 624 | 0 |
|
| Pax2 mutant mice display increased number and size of islets of Langerhans but no change in insulin and glucagon content | European journal of endocrinology | | | 2004 | 705 | 0 |
|
| Islet autotransplantation for the prevention of surgical diabetes after extended pancreatectomy for the resection of benign tumors of the pancreas | Transplantation proceedings | | | 2004 | 814 | 0 |
|
| Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations | Transplantation proceedings | | | 2004 | 807 | 1 |
|
| Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1 | The Journal of clinical endocrinology and metabolism | | | 2003 | 642 | 0 |
|
| Islet autotransplantation after left pancreatectomy for non-enucleable insulinoma | American journal of transplantation | | | 2003 | 865 | 736 |
|
| Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients | Transplantation | | | 2003 | 763 | 1 |
|
| Ectopic expression of the beta-cell specific transcription factor Pdx1 inhibits glucagon gene transcription | Diabetologia | | | 2003 | 706 | 229 |
|
| Molecular detection of circulating beta-cells after islet transplantation | Diabetes | | | 2002 | 745 | 406 |
|
| An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events | Diabetologia | | | 2002 | 497 | 0 |
|
| Human islet allotransplantation with Basiliximab in type I diabetic patients with end-stage renal failure | Transplantation proceedings | | | 2002 | 731 | 0 |
|
| Hepatic nuclear factor-3 (HNF-3 or Foxa2) regulates glucagon gene transcription by binding to the G1 and G2 promoter elements | Molecular endocrinology | | | 2002 | 537 | 0 |
|
| Pdx1 level defines pancreatic gene expression pattern and cell lineage differentiation | The Journal of biological chemistry | | | 2001 | 669 | 1,760 |
|
| Insulin independence and normalization of oral glucose tolerance test after islet cell allotransplantation | Transplant international | | | 2001 | 825 | 0 |
|
| Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations | Transplantation | | | 2000 | 731 | 0 |
|
| Le traitement du diabète par transplantation: quelles sont les indications | Médecine et hygiène | | | 2000 | 676 | 0 |
|
| Transplantation d'îlots de Langerhans: Quo vadis? | Médecine et hygiène | | | 1998 | 678 | 0 |
|
| Results of human islet allotransplantation in cystic fibrosis and type I diabetic patients | Transplantation proceedings | | | 1998 | 760 | 0 |
|
| Ablation of islet endocrine cells by targeted expression of hormone-promoter-driven toxigenes | Proceedings of the National Academy of Sciences of the United States of America | | | 1994 | 638 | 1 |
|
| Air in the bones: multifocal anaerobic osteomyelitis associated with oat cell carcinoma | BMJ. British medical journal | | | 1985 | 580 | 0 |
|
| Increased clearance and degradation of [3H]insulin in streptozotocin diabetic rats | The Journal of clinical investigation | | | 1981 | 599 | 0 |
|
| Resistance against subcutaneous insulin successfully managed with aprotinin | Lancet | | | 1980 | 677 | 0 |
|
| Inhibition of degradation of insulin by ophthalamic acid and by a bovine pancreatic proteinase inhibitor | Biochemical journal | | | 1979 | 647 | 0 |
|
